GGrantIndex
← Search

CLINICAL TRIAL: A PHASE I, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RA

$213,440M01FY2008RRNIH

Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center, Torrance CA

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →